Surgical technologies in treatment of patients with a metabolic syndrome


Cite item

Full Text

Abstract

The results of treatment of 407 patients, underwent to bariatric interventions. In 359 cases various bariatric operations were done, in 48 cases the intragastric balloon was established. After bariatric interventions, in terms from one till two years, 36 remedial surgical procedures were performed. Among patients who underwent various remedial surgical procedures, in 21 case abdominoplasty was performed, in 11 – mammoplasty, in 29 – a liposuction, in 14 – a plasticity of a medial surface of hips. Remedial surgical procedures are expedient for carrying out after bariatric interventions after stabilization of decrease in weight that allows to gain high-grade therapeutic and esthetic effect and to improve quality of life of patients.

About the authors

Клиническая больница №122 им. Л.Г.Соколова, г. Санкт-Пебербург

Author for correspondence.
Email: author@vestnik-surgery.com
д.м.н., профессор кафедры факультетской хирургии СанктПетербургского государственного медицинского университета им. академика И.П.Павлова, руководитель Центра хирургических методов лечения ожирения и метаболических нарушений в клинической больнице №122 им. Л.Г.Соколова г. СанктПетербурга;

Санкт-Петербургский государственный медицинский университет им. академика И.П.Павлова

Email: author@vestnik-surgery.com
д.м.н., профессор, заведующий кафедрой факультетской хирургии Санкт-Петербургского государственного медицинского университета им. академика И.П.Павлова

Клиническая больница №122 им. Л.Г.Соколова, г. Санкт-Пебербург

Email: author@vestnik-surgery.com
к.м.н., врач-хирург центра хирургических методов лечения ожирения и метаболических нарушений в клинической больнице №122 им. Л.Г.Соколова г. Санкт-Петербурга;

Клиническая больница №1 им. С.В.Очаповского, г. Санкт-Пебербург

Email: author@vestnik-surgery.com
аспирант кафедры факультетской хирургии Санкт-Петербургского государственного медицинского университета им. академика И.П.Павлова;

Клиническая больница №1 им. С.В.Очаповского, г. Санкт-Пебербург

Email: author@vestnik-surgery.com
врач-хирург клинической больницы №1 им. С.В.Очаповского г. Санкт-Петербурга, соискатель кафедры факультетской хирургии Санкт-Петербургского государственного медицинского университета им. академика И.П.Павлова;

References

  1. Belousov A.E. Plasticheskaia rekonstruktivnaia i esteticheskaia khirurgiia. SPb.: «Gippokrat» 1998; 743.
  2. Beliakov N.A., Mazurov V.I. Ozhirenie. Rukovodstvo dlia vrachei. SPb. 2003; 519.
  3. Butrova S.A. Ozhirenie (etiologiia, patogenez, klassifikatsiia). Ozhirenie. Metabolicheskii sindrom. Sakharnyi diabet 2 tipa. Pod red. I.I.Dedova. M.: Meditsina 2000: 12-13.
  4. Dedov I.I., Mel'nichenko G.A. Ozhirenie: Rukovodstvo dlia vrachei. M. 2004; 449.
  5. Sedov V.M., Fishman M.B. Laparoskopicheskaia khirurgiia ozhireniia. Prakticheskoe rukovodstvo. SPb. 2009; 192.
  6. American Society for Bariatric Surgery data 2003.
  7. Avogaro P., Crepaldi G., Enzi G., Tiengo A. Association of hyperlipidemia, diabetes mellitus and mild obesity. Acta Diabetol Lat. 1967; 4: 572-590.
  8. Buchwald H., Williams S. E., MattsJ. P., Nguyen Ph. A., Been R. Overall Mortality in the Program on the Surgical Control of the Hyperlipidemias. Amer. Coll. Surg. 2002; 195; 3: 327-331.
  9. Buchwald H., Rucker R.D.J. A history of morbid obesity. Advances in Gastrointestinal Surgery. 1984. J. S. Najarian, Delaney, J.P. Chicago, Year Book Medical Publishers: 235249.
  10. Camus J.P. Gout, diabetes, hyperlipemia: a metabolic trisyndrome. Rev Rhum Mal Osteoartic. 1966; 33(1):10-14.
  11. Deitel M. Overlooked problems in morbidly obese patients. Obes. Surg. 2001; 11; 541.
  12. Editoral. The European Charter on Counteracting Obesity. Obes. Surg. 2007; 17:143-144.
  13. European Charter on Counteracting Obesity. www.euro. who.int/document/E89567.pdf (accessed January 16, 2007).
  14. Flegal K.M., Carrol M.D., Ogden C.L. et al. Prevalence and trends in obesity among US adalts, 1999-2000. JAMA 2002; 288: 1723-1727.
  15. Hess D.S. Biliopancreatic diversion with a duodenal switch procedure. Obes. Surg. 1994; 4: 106.
  16. Hess, D.S., Hess D.W. "Biliopancreatic diversion with a duodenal switch." Obes. Surg. 1998; 8(3): 267-282.
  17. Kaplan N.M. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch.Intern. Med. 1989; 149: 1514 – 1520. 18. Kolle K., Bo O., Stadaas J. Surgical treatment of Obesity. Scand. J. Gastroenterology 1982; 17: 37- 40.
  18. Kuzmak L.A. review of seven years experience with Silicone Gastric Banding. Obes. Surg. 1991; 1: 403- 408.
  19. Kuzmak L., Abramson D. Future plans in Adjustable Silicon Gastric Banding reversibility without laparotomy, potential as a laparoscopic operation. Obes. Surg. 1993; 3: 98.
  20. Marceau P., Biron S., et al. Biliopancreatic diversion with a new type of gastrectomy. Obes. Surg. 1993; 3: 29-35.
  21. Mason E.E. Posting of Outcome: Voluntary or Required? Obes. Surg. 2004; 14: 1-2.
  22. National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identifi cation, evaluton, and treatment of overweight and obesity in adults: the evidence report. - Bethesda, MD: National Institutes of Health 1998. NIH Publication; 98; 4083.
  23. Reaven G.M., Laws A. Insulin Resistence. The Metabolic Syndrome X. HUMANA PRESS 1999; 373.
  24. Scopinaro N., Gionetta E., Friedman D. Evolution of biliopancreatic diversion. Clin. Nutr. 1986; 5: 137- 146. 26. Seidell J.S. The worldwide epidemic of obesity. Progress in obesity research. 8th International congress on obesity. Eds B. Guy-Grand, G. Ailhaud. London: John Libbey & Company Ltd. 1999; 661-668.
  25. WHO Global Strategy on Diet. Physical Activity and Helf. 2003; 4.
  26. WHO. Prevention and management of the global epidemic of obesity. Report of the WHO Consultation on Obesity (Geneva, 3-5 June, 1997). Geneva: WHO.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies